FDA Commissioner Dr. Marty Makary: We've never had this 'essential' conversation on health
FDA Commissioner Dr. Marty Makary addresses why obesity is on the decline and discusses the Trump administration's deal that slashes related drug costs on 'The Evening Edit.'
Pfizer wins 'fantastic deal' after $10B obesity drug fight with Novo Nordisk
Pfizer Chairman and CEO Albert Bourla joins 'Mornings with Maria' to discuss the company’s $10 billion acquisition of obesity drug startup Metsera, its competition with Novo Nordisk and his plans to expand their weight-loss drug pipeline.
Weight-loss pills replacing GLP-1 shots will be ready by March, Dr. Oz tells FOX Business
Oral GLP-1 weight loss pills could replace injections by March 2026 at $150 monthly, Medicare chief Dr. Mehmet Oz predicted in a FOX Business appearance.
Pfizer wins $10B bidding war for obesity drug developer Metsera in major pharmaceutical acquisition
Pfizer has won a $10 billion deal to acquire obesity drug developer Metsera, securing foothold in lucrative weight-loss treatment market.
Southwest rolls out new conditions for plus-size passenger refunds
Plus-size travelers must buy extra seats on Southwest flights with assigned seating, with refunds only available if flights depart with open seats.
FDA chief explains how agency is 'rewriting the food pyramid'
FDA commissioner Dr. Marty Makary outlines the issues associated with petroleum-based food dyes and the 'bigger issue' the agency aims to tackle on 'The Evening Edit.'
Novo Nordisk CEO steps down as Wegovy maker faces increased competition
As Novo Nordisk's share price drops, CEO Lars Fruergaard Jorgensen steps down. The company aims to maintain its lead in the competitive weight-loss drug market.
Wegovy, the weight-loss medication, gets FDA approval for use as heart disease prevention drug
Wegovy has been FDA-approved for heart disease prevention. The semaglutide, originally approved for weight loss, is now approved to reduce the risk of cardiovascular death, heart attack and stroke.
Southwest Airlines celebrated for policy to give a full row to 'passengers of size' for free
TikTokers have recently discovered Southwest Airlines' inclusion policy to provide one or two additional seats to 'passengers of size' at no extra cost.
FDA approves Eli Lilly's tirzepatide for weight loss
Eli Lilly's drug tirzepatide was approved by the Food and Drug Administration to help people who are overweight and have a weight-related medical condition lose weight.